Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 10 of 16
Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients
NCT02763943
Oxytocin and Stress Response in Alcohol Use Disorder
NCT03610633
Assessing the Bite Counter
NCT02763358
Evaluation of the Duration of Bupivacaine Spinal Block in Orthopedic Procedures With and Without Epinephrine Wash
NCT02619409
Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System
NCT03103061
Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
NCT02426229
ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer
NCT02523469
Exercise and Brain Stimulation for Post-stroke Depression
NCT03056287
Examining Measurement of Behavioral Neglect Post Stroke
NCT02935270
Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues
NCT02939313
Sensory Stimulation to Enhance Hand Function Post Stroke
NCT02675764
Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).
NCT03163186
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
NCT02638298
Tin Filter Calcium Scoring
NCT02855528
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant
NCT02687763
Marijuana Approach Bias Retraining and Neural Response in Youth
NCT02723149
Wide Spectrum Investigation of Stroke Outcome Disparities on Multiple Levels (WISSDOM)
NCT02982278
Theta Burst TMS as a Tool to Change Smoking Behavior
NCT02939339
Motor-Sparing Peripheral Nerve Blockade Facilitates Mobility Post Total Knee Arthroplasty: A Randomized Controlled Trial
NCT02773537
Safety and Efficacy of a Novel Facemask for Positive Pressure Ventilation
NCT03158207
Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults
NCT03039491
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
NCT02476279
Longitudinal Assessment of Functional Connectivity in Treatment Engaged Cocaine Users
NCT03554928
The Effects of Cognitive Behavioral Therapy and Transcranial Current Stimulation (tDCS) on Chronic Lower Back Pain
NCT02483468
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
NCT02911337
Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment
NCT02535572
Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma
NCT02512692
Smart Capsule for Automatic Adherence Monitoring
NCT02344238
DYNA EMBOLIZATION - Pilot Study of IV Dyna CT and CBV Imaging Techniques
NCT03528200
Neural Substrates of Emotion: Impact of Cocaine Dependence
NCT02682784
Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation
NCT03563404
Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence
NCT02626156
Bamberg Diabetes Transitional Care Pilot Study
NCT02560090
Pregnenolone and Marijuana Dependence
NCT02439814
COMPASS Trial: a Direct Aspiration First Pass Technique
NCT02466893
Physical Activity Interventions for Leg Ulcer Patients
NCT02632695
Intravenous Versus Oral Acetaminophen for Postoperative Pain Control After Cesarean Delivery
NCT02487303
Postural Control and Fine Motor Skills in People With Stroke
NCT03364374
Paired Associative Stimulation in Stroke
NCT02586597
Alpha-1 Carrier Genomics Study
NCT02810327
Carbon Monoxide-Saturated Medium for Islet Isolation
NCT02567240
Imaging Laterality in Chronic Stroke Patients
NCT03584425
Optimizing Current and Electrode Montage for Transcranial Direct Current Stimulation in Stroke Patients
NCT02763826
Mesenchymal Stem Cell and Islet Co-transplantation
NCT02384018
The Effects of CBT and tDCS on Fibromyalgia Patients
NCT02723175
Compare Epidural vs. Lumbar Plexus Analgesia After Hip Arthroplasty
NCT02493621
Myocardial Stress Perfusion Computed Tomography in the Evaluation of Patients With Acute Chest Pain Using a Novel 3rd Generation Dual-source CT System
NCT02308475
Sedline 4 Channel Electroencephalogram (EEG) Monitoring During Suppression of Unilateral Hemispheric Function (Wada Test
NCT02503878
A Trial of E-cigarettes in Current Cigarette Smokers
NCT02357173
Gabapentin for Alcohol Relapse Prevention
NCT02349477
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.